This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Jingxin Biology & Pharmaceutical Co., Ltd, Zhejiang Jingxin Pharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Xiaoyun Fu
Introduction
Xiaoyun Fu is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on cyclohexane derivatives. His research has led to advancements that have practical applications in clinical settings.
Latest Patents
Xiaoyun Fu holds a patent for a salt of a cyclohexane derivative. The invention provides a maleate, phosphate, sulfate, and hydrochloride of a cyclohexane derivative, specifically N'-[trans-4-[2-[7-(benzo[b]thiophene)-7-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea. The crystal forms of this compound exhibit low hygroscopicity and good stability, making them convenient for long-term storage and transportation. Additionally, these crystal forms demonstrate a long half-life in vivo, high bioavailability, and minimal individual differences, which highlight their clinical application advantages.
Career Highlights
Xiaoyun Fu has worked with prominent companies in the pharmaceutical industry, including Shanghai Jingxin Biology & Pharmaceutical Co., Ltd. and Zhejiang Jingxin Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to further develop his expertise and contribute to innovative solutions in drug formulation.
Collaborations
Xiaoyun Fu has collaborated with several professionals in his field, including Yue Huang and Fei Zheng. These partnerships have facilitated the exchange of ideas and fostered advancements in their shared research interests.
Conclusion
Xiaoyun Fu's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to have a significant impact on clinical applications and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile